 SOUTH SAN FRANCISCO, Calif., May 10, 2021 GLOBE NEWSWIRE -- Fluidigm Corporation Nasdaq:FLDM, an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will host a virtual investor event that will showcase competitive advantages of CyTOF technology, preview a new product that will enhance the capabilities of a Fluidigm mass cytometry platform, and provide updates on the companys innovation pipeline and key customer relationships. 